| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |